And It's About Time There Was Some Support For Cushing's!
From The Office of Rare Diseases
Requested and adapted from a publication provided by the NCI
Research studies conducted with patients are called clinical trials. As a patient with a rare disease or condition, you may take part in a clinical trial. This guide is written for you, your family and friends, to explain what clinical trials are and to help you make a decision about entering a trial.
The time when your disease is diagnosed or when treatment decisions are being made is very difficult. It is often hard to understand or remember complex medical explanations. The information in this guide is meant to supplement what your doctors tell you. It provides answers to questions asked most often about clinical trials.
You may wish to write down questions to ask your doctor or nurse. Also, there is a glossary of words that relate to clinical trials. This is a quick way to look up terms that you may hear or read. More information on many disease-related topics is available at no cost in other publications from NIH.
We hope this guide will help to explain how clinical studies are designed and carried out. Of course, there are good treatments and good care for patients whether they take part in clinical trials or receive standard treatments. You may decide not to take part in a trial, and you can still receive good medical care. The decision to enter a clinical trial or not is always up to you.
In medical research, a clinical trial is a study conducted with patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help patients.
The search for good treatments begins with basic research in laboratory and animal studies. The best results of that research are tried in patient studies, hopefully leading to findings that may help many people.
Before a new treatment is tried with patients, it is carefully studied in the laboratory. This research points out the new methods most likely to succeed, and, as much as possible, shows how to use them safely and effectively. But this early research cannot predict exactly how a new treatment will work with patients.
With any new treatment there may be risks as well as possible benefits. There may also be some risks that are not yet known. Clinical trials help us find out if a promising new treatment is safe and effective for patients. During a trial, more and more information is gained about a new treatment, its risks, and how well it may or may not work.
Standard treatments, the ones now being used, are often the base for building new, hopefully better treatments. Many new treatments are designed on the basis of what has worked in the past, in efforts to improve on this.
Only patients who wish to, take part in a clinical trial. You may be interested in or asked to enter a trial. Learn as much as you can about the trial, before you make up your mind.
Advances in medicine and science are the results of new ideas and approaches developed through research. New treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made widely available.
Through clinical trials, researchers learn which approaches are more effective than others. This is the best way to test a new treatment. A number of standard treatments were first shown to be effective in clinical trials. These trials helped to find new and better treatments.
Patients take part in clinical trials for many reasons. Usually, they hope for benefits for themselves. They may hope for a cure of disease, a longer time to live, a way to feel better. Often they want to contribute to a research effort that may help others.
Based on what researchers learn from laboratory studies, and sometimes earlier clinical studies and standard treatments as well, they design a trial to see if a new treatment will improve on current treatments. The hope is that it will. Often researchers use standard treatments as the building blocks to try to design better treatments.
Although there is always a chance that a new treatment will be disappointing, the researchers involved in a study have reason to believe that it will be as good as, or better than, current treatments.
The patients in a clinical trial are among the first to receive new research treatments before they are widely available. How a treatment will work for a patient in a trial can't be known ahead of time. Even standard treatments, although effective in many patients, do not carry sure benefits for everyone. But patients should choose if they want to take part in a study or not, only after they understand both the possible risks and benefits.
The patients who take part in clinical trial procedures that do prove to be better treatments have the first chance to benefit from them. All patients in clinical trials are carefully monitored during a trial and followed up afterwards. They become part of a network of clinical trials carried out around the country. In this network, doctors and researchers pool their ideas and experience to design and monitor clinical studies. They share their knowledge from many specialties about treatment and care. Patients in these studies receive the benefit of their expertise. At medical centers, patients receive care from a special research team. Through new programs, community hospitals and doctors are also coming more and more into the research network.
Yes. The treatments used in clinical trials can cause side effects and other health risks depending on the type of treatment and the patient's condition. Side effects vary from patient to patient.
Because clinical trials are research into new areas of treatment, the risks involved are not always known ahead of time, though efforts have been made to find out what they might be. For this reason, trials can carry unknown dangers and side effects as well as hoped-for benefits.
Patients need to know what is involved in a study-what side effects may be expected- and, as much as possible, what unknowns or uncertainties they may be facing.
Your doctor or nurse will tell you about the treatments being tested and will give you a form to read that discusses the risks and hoped-for benefits. If you agree to take part, you will be asked to sign a form, called the informed consent form. Before you sign, be sure you understand what risks you face. Ask the doctor or nurse to explain any parts of the form or the trial that are not clear. If you do not want to be in the trial, you may refuse. Even if you sign the form, you are free to leave the trial at any time and can receive other available medical care.
In clinical trials, most side effects are temporary and will gradually go away once treatment is stopped. For example, some drugs cause hair loss and nausea and some do not. They can also affect the bone marrow which produces blood cells. During treatment, the number of blood cells, called blood counts, may fall too low. Since this could lead to possible infection or other problems, patients have their blood counts checked often. Luckily, bone marrow has a great ability to replace blood cells, so that blood counts can usually return to normal.
Some side effects in clinical trials can be permanent and serious, even life-threatening. Also, certain side effects may not appear until later, after the treatment itself is over. (These "late" effects may include damage to a major organ like the heart, lungs, or kidneys; or sterility.) Many patients are now living longer, largely because of better treatments. Researchers are concerned and trying to prevent late complications of treatments.
As a patient, it can be hard to decide about your treatment. There are a number of things to consider. Many medical conditions are life-threatening diseases. In each case, the unavoidable risks of the disease itself, and your condition, should be weighed against the potential risks and benefits of a new research treatment. Standard treatments, as well as treatments in clinical trials, can also cause side effects and risks.
Every clinical trial is designed to answer a set of research questions. If you fit the guidelines for a trial, you may be eligible to take part. Each study enrolls patients with certain types and stages of cancer and certain health status. A study that involves two or more treatments can yield reliable answers only if all the patient cases are the same, so they can be compared with each other.
Before you and your physician make a decision about your treatment (whether it is in a clinical trial or not), your type of cancer will be diagnosed and "staged." Staging tells how far the disease has spread. Deciding on treatment depends on many things, including the stage of the disease and your general health. You would most likely be referred to a trial by your own doctor or by a doctor who knows your case. Some patients find out about trials from other sources. In any case, you must have a reasonable understanding of your role in a research study and be freely willing to take part in it. Ask what you can expect if you take part in a trial.
There are many ways to find out what your treatment choices are. Talk with your doctors and get the opinion of cancer specialists oncologists). You should not be afraid to ask for a second opinion. A helpful treatment information system called PDQ is supported by the National Cancer Institute. PDQ can give your doctor the latest information on clinical trials being offered around the country for each type and stage of cancer.
This ready reference is kept up to date. Your doctor can check it from a medical library or personal computer.
The Cancer Information Service (CIS) is another source of information.
This program, also sponsored by the National Cancer Institute, answers cancer-related questions from the public, cancer patients and their
families, and health professionals. If you have questions, call the toll-free number: 1-800-4-CANCER and you will be connected to the CIS office
serving your area. Spanish-speaking CIS staff are also available at this
number.
This is a big question. Finding answers and making decisions are often hard for a cancer patient. The diagnosis of cancer and deciding what to do about it can be overwhelming, and you may be confused and upset. It is important to discuss your options with medical experts including your own doctor and with those close to you. Your personal doctor, who may be your family doctor, and cancer specialists can counsel you about your choices for standard treatment or clinical trials.
Talk to them and ask questions about the problems you are facing. If you understand what is going on, you can help your doctor work with you more effectively. You may want to take a friend or relative along with you when you talk to your doctor about your case.
Take time to ask your questions and to discuss what you want to know. It may help you and your doctor if you plan what to ask and write questions down ahead of time. No question is foolish. Learn what is available to you. Find out your choices and the risks and benefits of each.
Each patient is different. You are an individual with individual needs, and your health is important. If you are a parent of a child with cancer, of course you have great concerns about making the best decision for your child's care.
As you decide about treatment, if it is in a clinical trial or not, remember that you are not alone. There are many people to help you doctors, nurses, social workers, clergy, your family, friends, and other patients. Although is it YOUR decision, they can help you think about it and decide what is best for you.
If you are thinking about taking part in a clinical trial, here are some important questions to ask:
*Costs are a major concern of patients and families. Different arrangements and policies exist at different institutions and, of course, insurance coverage varies. Patients should freely discuss what costs are involve their cases ahead of time. If you need financial aid, contact the hospital social services office, the Cancer Information Service, or the local American Cancer Society Chapter. They may be able to direct you to a source of help.
Informed consent, a key part of a good trial, is required in studies that are federally regulated or funded as well as by many state laws. Informed consent means that as a patient, you are given information so you can understand what is involved in a trial, including its potential benefits and risks, and then decide freely to take part in it or not. The nature of the treatment is explained by the doctors and nurses in the trial. You are given an informed consent form to read and consider carefully. Ask any questions you may have. Then, if you agree to take part, you can sign the form. Of course, you can also refuse.
The informed consent process is an ongoing process. If you enter a trial, you will continue to receive any new information about your treatment that may affect your willingness to stay in the trial. Signing a consent form does not bind you to the study. You can still choose to leave the study at any time.
Whether cancer patients are in a research study or not, they face a new world of medical terms and procedures. For some people, myths and fears of "experimentation" or of being a "guinea pig" come with the idea of clinical trials. And, surely, there are fears of the unknown.
Understanding what is involved can ease some of your anxieties. Patients in a clinical trial, for example, receive their care in the same places that standard treatments are given-at cancer centers, hospitals, clinics, or doctors' offices.
Because a growing number of cancer specialists are now in private practice in the community, most cancer care can be given in an area near your home. Doctors, nurses, social workers and other health professionals from many different specialties may help care for you. They are working together for your good. There is consideration for your privacy and well-being.
If you join a research study, you will be watched closely and data on your case will be carefully recorded. You may receive more examinations and tests than are usually given. (These are to follow your progress as well as to collect study data.) Of course, tests can carry certain risks and benefits or discomforts of their own. Although they can be inconvenient, these tests can assure an extra ounce of observation along the way.
During the course of a study, if it is clear that a treatment is not in your best interest, you will be removed from the study and you can discuss other options with your physician.
Yes. Just as you can refuse to join a study, you may leave a study at any time. Your rights as an individual do not change because you are a patient in a clinical trial. You may choose to take part or not, and you can always change your mind later, even after you enter a trial.
You may also refuse to take part in any aspect of the research. If you have questions at any time about any part of the study, be sure to ask your doctors. If you are not satisfied with the answers, you may consider leaving the study. If you decide to leave, it will not be held against you. You can freely discuss other possible treatments and care with your doctors and nurses.
The ethical and legal codes that govern medical practice apply to clinical trials. In addition, most clinical research is federally regulated or federally funded (at least in part), with built-in safeguards to protect patients. These safeguards include regular review of the protocol (the study plans) and the progress of each study by researchers at other places.
For example, federally funded and federally regulated clinical trials must first be approved by an Institutional Review Board (IRB) located at the institution where the study is to take place. IRBs, designed to protect patients, are made up of scientists, doctors, clergy and other people from the local community. An IRB reviews a study to see that it is well designed with safeguards for patients and that the risks are reasonable in relation to the potential benefits.
Federally supported or regulated studies also go through reviews by a government agency such as the National Cancer Institute**, which sponsors and monitors many trials around the country.
Any well run clinical trial, whether federally supported or not, is carefully reviewed for medical ethics, patient safety, and scientific merit by the research institution. Every study should provide for monitoring the data and the safety of patients on an ongoing basis.
As discussed earlier, informed consent is also an important process that helps to protect patients.
After patients join a clinical trial and it progresses, the doctors report the results of the trial to scientific meetings, to medical journals whose articles are approved by experts, and to various government agencies.
**The National Cancer Institute (NCI) is the Federal Government's chief agency for cancer research. Located at the National Institutes of Health (NIH) in Bethesda, Maryland, the Institute funds cancer research across the country and conducts research at its own facilities. For information about NCI trials, call: 1-800-4-CANCER.
Here are some important questions for you to ask to find out if a study is well run:
For your own protection, be sure to get satisfactory answers to these questions before you agree to take part.
There are many kinds of clinical trials. They range from studies of ways to prevent, detect and diagnose, control and treat cancer, to studies of the psychological impact of the disease and ways to improve the patient's comfort and quality of life (including pain control).
Most cancer clinical trials deal with new treatments. These treatments often involve surgery, radiation therapy (the use of x-rays, neutrons or other types of cell-destroying radiation), and chemotherapy (the use of anticancer drugs). Alone, or in combination, these types of treatments can cure many cancer patients and prolong the lives of many others. A fairly new area of cancer treatment is biological therapy-the use of biologicals (substances produced by the body's own cells) and biological response modifiers (substances that affect the body's natural defense systems against disease).
Clinical trials are carried out in phases, each designed to find out certain information. Patients may be eligible for studies in different phases depending on their general condition and the type and stage of their cancer. More patients take part in the later phases of studies than in the earlier ones.
In a Phase I study, a new research treatment is given to a small number of patients. The researchers must find the best way to give a new treatment and how much of it can be given safely. They watch carefully for any harmful side effects. The research treatment has been well tested in laboratory and animal studies but no one knows how patients will react. Phase I studies may involve significant risks for this reason. They are offered only to patients whose cancer has spread and who would not be helped by other known treatments. Phase I treatments may produce anticancer effects, and some patients have been helped by these treatments.
Phase II studies determine the effect of a research treatment on various types of cancer. Each new phase of a clinical trial depends on and builds on information from an earlier phase. If a treatment has shown activity against cancer in Phase II, it moves to Phase III. Here it is compared with standard treatment to see which is more effective. Often researchers use standard therapy as the base to design new, hopefully better treatments. Then in Phase III, the new treatment is directly compared to the old one. In Phase IV studies, the new research treatment becomes part of standard treatment in patient care. For example, a new drug that has been found effective in a clinical trial may then be used together with other effective drugs or with surgery and/or radiation therapy.
The doctors who conduct a clinical trial follow a carefully designed treatment plan called a "protocol." This spells out what will be done and why. Studies are planned to safeguard the medical and psychological health of patients as well as to answer research questions.
Some clinical trials test one research treatment in one group of patients. Other trials compare two or more treatments in separate groups of patients who are similar in certain ways such as the extent of their disease. This way, the treatment groups are alike, and the results from each can validly be compared.
One of the groups may receive standard (the most accepted) treatment so the new treatments can be directly compared to it. The group receiving the standard treatment is called the "control" group. For example, one group of patients (the control group) may receive the usual surgical treatment for a certain cancer, while another patient group with the same type of cancer may receive surgery plus radiation therapy to see if this improves disease control.
Sometimes, no standard treatment yet exists for certain cancer patients. In drug studies for such cases, one group of patients might receive a new drug and the control group, none. But no patient is placed in a control group without treatment if there is any known treatment that would benefit that patient. The control group is followed as often and carefully as the "treatment" group.
One of the ways to prevent the bias of a patient or doctor from influencing study results is "randomization." If a patient agrees to be randomized, this means he or she is selected by chance to be in one group or another. The researchers do not know which treatment is best. From what is known at the time, any one of the treatments chosen could be of equal benefit to the patient.
If the treatment in a trial is not helping the patient, the patient's doctor can decide to take him or her out of the study. Of course, the patient can decide to leave, as well, and still receive other available care. There are regular reviews of the results of a trial and the information is shared. This is important, because if a treatment is found to be too harmful or not effective, it is stopped. Also, when there is firm evidence that one method is better than the others in a study, the trial is stopped and all patients in the trial are given the benefit of the new information. Such information may help present and future patients.
Throughout a clinical study, a patient's personal doctor will be kept informed of the patient's progress. Patients are encouraged to maintain contact with their referring doctors.
